Test Id : FCICP
Circulating Immune Complex Panel
Method Name
A short description of the method used to perform the test
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
Aliases
Lists additional common names for a test, as an aid in searching
C1q binding; CIC
CIC-Raji Cell Replacement assay
Circulating Immune Complex Panel
C1q binding Immune Complexes
C3 fragment containing immune complexes
Specimen Type
Describes the specimen type validated for testing
Serum
Shipping Instructions
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Collection Container/Tube:
Preferred: Red Top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 2 mL
Collection Instructions:
1. Draw blood in plain, red-top tube(s) or serum gel tube(s).
2. Allow complete clotting of red blood cells (up to 1 hour)
3. Within 30 minutes of clotting completion, centrifuge and aliquot 2 mL into a plastic vial.
3. Freeze immediately.
4. Ship frozen.
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.
1 mL
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
| Gross hemolysis: | Reject |
| Thawing: | Cold reject; Warm reject |
| Gross lipemia | Reject |
| Gross icterus | Reject |
| Ambient or refrigerated samples; Samples exposed to repeated freeze/thaw cycles | Reject |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Frozen | 14 days |
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Circulating Immune Complex, C1q Binding: 0.0-3.9 ug Eq/mL
Circulating Immune Complex, C3 fragments: Less than or equal to 15 ug Eq/mL
Interpretation
Provides information to assist in interpretation of the test results
Circulating Immune Complex, C1q Binding:
Less than or equal to 3.9 ug Eq/mL is considered negative for circulating complement binding immune complexes.
Circulating immune complexes may be found without any evident pathology and positive results do not necessarily implicate the immune complex in a disease process.
Circulating Immune Complex, C3 fragments:
Many autoimmune disorders, chronic infections and malignancies are associated with circulating immune complexes. Quantitation of immune complexes assists in staging immunologic disorders. Detection of circulating immune complexes is not essential to any specific diagnosis. Circulating immune complexes may be found without any evident pathology and positive results do not necessarily implicate immune complex-related disease process. Values between 15 and 20 ug Eq/mL are considered equivocal for Circulating Immune Complex, C3 fragments assay. Repeat- testing using a new specimen is recommended, if clinically indicated.
PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.
Saturday, Monday, and Thursday
Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
Performing Laboratory Location
Indicates the location of the laboratory that performs the test
Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their account representative. For assistance, contact Customer Service.
CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
CPT codes are provided by the performing laboratory.
86332 x 2
LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.
| Test Id | Test Order Name | Order LOINC Value |
|---|---|---|
| FCICP | Circulating Immune Complex Panel | Not Provided |
| Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
|---|---|---|
| Z6375 | CIC, C1q Binding | 27831-7 |
| Z6376 | CIC, C3 fragments | 5228-2 |